Skip to main content
NDT Plus logoLink to NDT Plus
. 2011 Apr 12;4(4):276–277. doi: 10.1093/ndtplus/sfr049

A fast-growing skin lesion in a dialysis patient

Marco Bonani 1,, Isabelle Binet 1, Pierre-André Diener 2, Dimitrios Tsinalis 1
Editor: G H Neild
PMCID: PMC4421447  PMID: 25949503

Case

One year after kidney transplantation, a 70-year-old man returned to haemodialysis. Induction had consisted in basiliximab, mycophenolate, prednisone and cyclosporine, the latter was switched to tacrolimus after 9 months. Because of rejection under reduced immunosuppression, the graft was removed 6 months after returning to haemodialysis and immunosuppression was completely stopped.

Twelve months later, a large skin tumour grew close to the arteriovenous fistula within 4 weeks (Figure 1). A surgical excision was undertaken. Macroscopy showed a spindled skin specimen with a centrally located dome-shaped nodule. On histological examination, the tumour presented with crateriform architecture and centrally located papillary proliferation within a keratin plug consistent with the diagnosis of a keratoacanthoma (Figures 2 and 3). Keratoacanthomas are benign skin tumors developing from epidermal and hair follicle keratinocytes. Even after histological examination, keratoacanthomas are hard to distinguish from squamous cell carcinoma [1], the most frequent skin cancer after transplantation [2]. Additionally, both tumours have similar risk factors such as ultraviolet light and human papillomavirus infection [3].

Fig. 1.

Fig. 1.

1.6 × 1.5 × 0.5 cm measuring keratoacanthoma close to the arteriovenous fistula used for dialysis access.

Fig. 2.

Fig. 2.

Margin of a keratin-filled crater with papillary proliferation of the squamous epithelium.

Fig. 3.

Fig. 3.

Mild cellular atypia, on the right side an intraepithelial micro-abscess.

Hence, after returning to chronic haemodialysis, a regular dermatological examination is mandatory for previously transplanted patients.

Acknowledgments

Conflict of interest statement. None declared.

References

  • 1.Cooper SM, Wojnarowska F. The accuracy of clinical diagnosis of suspected premalignant and malignant skin lesions in renal transplant recipients. Clin Exp Dermatol. 2002;27:436–438. doi: 10.1046/j.1365-2230.2002.01069.x. [DOI] [PubMed] [Google Scholar]
  • 2.Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation. 2004;77:574–579. doi: 10.1097/01.tp.0000108491.62935.df. [DOI] [PubMed] [Google Scholar]
  • 3.Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681–1691. doi: 10.1056/NEJMra022137. [DOI] [PubMed] [Google Scholar]

Articles from NDT Plus are provided here courtesy of Oxford University Press

RESOURCES